XML 90 R15.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES:
The components of income tax expense were as follows:
 For the Years Ended December 31,
 202420232022
Current:   
U.S. Federal$34,009 $100,572 $45,068 
U.S. State1,413 7,287 7,238 
Non-U.S.— — (235)
 35,422 107,859 52,071 
Deferred:   
U.S. Federal9,557 12,528 37,154 
U.S. State(737)1,593 12,233 
 8,820 14,121 49,387 
    
Total Income Tax Expense$44,242 $121,980 $101,458 
A reconciliation of income tax expense and the amount computed by applying the statutory federal income tax rate of 21% to income from operations before income tax is:
 For the Years Ended December 31,
 202420232022
 AmountPercentAmountPercentAmountPercent
Statutory U.S. federal income tax rate$69,436 21.0 %$163,353 21.0 %$119,372 21.0 %
State income taxes, net of federal tax benefit3,017 0.9 7,618 1.0 11,110 2.0 
Effect of foreign income taxes— — — — (241)— 
Excess tax depletion(22,397)(6.8)(26,802)(3.5)(32,431)(5.7)
Foreign derived intangible income(4,501)(1.4)(23,545)(3.0)(4,906)(0.9)
Uncertain tax positions(1,452)(0.4)36 — (792)(0.1)
Compensation1,480 0.5 2,284 0.3 4,178 0.7 
Valuation allowance— — — — (937)(0.2)
Tax credits(1,000)(0.3)(700)(0.1)(350)(0.1)
State rate change and prior period adjustments(644)(0.2)(809)(0.1)5,397 0.9 
Other303 0.1 545 0.1 1,058 0.2 
Income Tax Expense / Effective Rate$44,242 13.4 %$121,980 15.7 %$101,458 17.8 %
Significant components of deferred tax assets and liabilities were as follows:
 December 31,
 20242023
Deferred Tax Asset:  
Asset retirement obligations$40,445 $41,400 
Postretirement benefits other than pensions40,226 47,730 
Pneumoconiosis benefits31,663 33,867 
Other44,735 28,280 
Total Deferred Tax Asset157,069 151,277 
   
Deferred Tax Liability:  
Equity Partnerships(155,039)(122,220)
Property, plant and equipment(39,154)(52,409)
Other(12,090)(12,867)
Total Deferred Tax Liability(206,283)(187,496)
   
Net Deferred Tax Liability$(49,214)$(36,219)
Certain prior period amounts in the table above were previously disclosed separately, but have been reclassified to Other to conform to the current year presentation.
At December 31, 2024, the Company has net operating loss carryforwards of approximately $1,097 for state income tax purposes, which will, if ultimately utilized, offset future taxable income. These net operating losses, if unused, will expire in 2041.
As required by U.S. GAAP, a valuation allowance is required when it is more likely than not that all or a portion of a deferred tax asset will not be realized. Management must review all available evidence, both positive and negative, in determining the need for a valuation allowance. As of December 31, 2024 and 2023, no valuation allowance has been recorded.
Unrecognized Tax Benefits
The Company utilizes the “more likely than not” standard in recognizing a tax benefit in its financial statements. For the years ended December 31, 2024 and 2023, a reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
 December 31,
 20242023
   
Balance at January 1$1,987 $1,941 
Additions based on tax positions related to the current year— 22 
Additions for tax positions of prior years— 24 
Settlements(1,987)— 
   
Balance at December 31$— $1,987 
The Company recorded an unrecognized tax benefit for the tax year ending December 31, 2023 of $1,987, related to a position taken on state taxes. The issue related to the unrecognized tax benefit was settled during 2024.
The Company is subject to taxation in the United States and its various states, as well as Canada and its various provinces. The Company is subject to examination for the tax periods 2020 through 2024 for federal and state returns.